CVS, Walgreens to Begin Selling Abortion Pills Later This Month

March 1, 2024 by Dan McCue
CVS, Walgreens to Begin Selling Abortion Pills Later This Month
A CVS Pharmacy in North Charleston, S.C. (Photo by Dan McCue)

WASHINGTON — The nation’s two largest pharmacy chains will start dispensing the abortion pill mifepristone in select states later this month, just weeks before the Supreme Court is set to hear a case that could lead to its removal from the market.

The decision by both CVS and Walgreens to make mifepristone available with a prescription at their pharmacy counters was originally reported by The New York Times.

The story got a quick, positive response from the White House, where President Joe Biden called the decision “an important milestone” to ensuring women’s access to the pill, which was approved by the Food and Drug Administration more than 20 years ago.

Officials at both chains said they had received certification to dispense mifepristone under guidelines the FDA issued last year. 

Both chains had indicated that they initially plan to make the medication available in just a handful of states, and then will gradually expand their sale in states where abortion is legal and where pharmacies are legally able to dispense abortion pills.

“With major retail pharmacy chains newly certified to dispense medication abortion, many women will soon have the option to pick up their prescription at a local, certified pharmacy — just as they would for any other medication,” Biden said.

He went on to encourage all pharmacies that want to join CVS and Walgreens in dispensing the pill to seek certification.

“The stakes could not be higher for women across America,” the president said.

Vice President Kamala Harris also acknowledged the decision by CVS and Walgreens at the conclusion of a campaign event in Durham, North Carolina.

“I want to acknowledge the decision today to allow two major pharmacies to make available mifepristone, which is medication abortion, in some states, and I would urge and challenge other pharmacies to do the same,” she said. 

“It was over a year ago that the Supreme Court took away a … right that had long been recognized by the American people, and since then, states throughout our country have further restricted the rights of women to make decisions about their own bodies, and to plan their own futures,” she said.

Later, without mentioning former President Donald Trump by name, Harris said, “Let’s remember that the architect of where we are now in the taking of these freedoms was the former president of the United States, who has boasted about the fact that he essentially handpicked three members of the nation’s highest court with the intention that they would undo the protections of Roe v. Wade.”

Walgreens will reportedly start providing the pill within the next week in a small number of its pharmacies in New York, Pennsylvania, Massachusetts, California and Illinois.

Fraser Engerman, a spokesman for the chain, told the Times the phased rollout in select locations would “allow us to ensure quality, safety and privacy for our patients, providers and team members.”

CVS will begin dispensing in all of its pharmacies in Massachusetts and Rhode Island at an unspecified date before the end of the month.

Both chains said they are continuing to monitor the fluid legal situation surrounding mifepristone in many states and indicated they would refrain from dispensing the drug in states where the law is unclear due to pending legal challenges.

On March 26, the Supreme Court will hear oral arguments in FDA v. Alliance for Hippocratic Medicine and Danco v. Alliance for Hippocratic Medicine, cases in which a group of doctors claim the FDA used a flawed process to initially approve the drug and, later, keep it on the market.

The conservative 5th U.S. Circuit Court of Appeal has ruled that the agency’s actions likely violated the law, and that its approval of mifepristone should be amended to block mail-order distribution of the drug and to require women to visit a doctor before it can be prescribed for them.

Abortion opponents roundly panned the pharmacies’ decision.

Katie Daniel, state policy director of Susan B. Anthony Pro-Life America, an anti-abortion group, said in a statement that CVS and Walgreens’ decision to sell “dangerous abortion drugs” was “shameful” and predicted that the harm to unborn babies and their mothers would be “incalculable.”

“This reckless policy was made possible by the Biden administration, which is pushing to turn every pharmacy and post office in America into an abortion center for the sake of abortion industry greed,” Daniel said. 

“Even when used under the strongest safeguards, abortion drugs send roughly one in 25 women to the emergency room, according to the FDA’s own label. Yet under Democrat presidents, the FDA has illegally rolled back basic safety standards, like in-person doctor visits, even allowing these deadly drugs to be sent through the mail,” she said.

Dr. Ingrid Skop, vice president and director of medical affairs at Charlotte Lozier Institute, another anti-abortion group, also criticized the decision.

“By pushing these medically unsupervised abortions, the FDA and abortion advocates continue down the slippery slope of chipping away at medical standards for women seeking abortion,” she said. “This is not health care. This is an ideology that prioritizes destruction of unborn human life and does not care that the women injured by these abortions … are collateral damage.”

Medication abortion is a two-drug regimen that is now the most common method of ending pregnancies in the United States.

Mifepristone, which blocks a hormone necessary for pregnancy development, is taken first, followed 24 to 48 hours later by misoprostol, which causes contractions that empty the uterus.

Dan can be reached at [email protected] and @DanMcCue

A+
a-
  • CVS
  • Joe Biden
  • Kamala Harris
  • mifepristone
  • In The News

    Health

    Voting

    Health

    May 8, 2024
    by Dan McCue
    House Panel Throws Unanimous Support Behind Telehealth Bill

    WASHINGTON — The House Ways and Means Committee unanimously advanced a bill on Wednesday that would extend Medicare’s COVID-era ability... Read More

    WASHINGTON — The House Ways and Means Committee unanimously advanced a bill on Wednesday that would extend Medicare’s COVID-era ability to support telehealth visits and pay for acute-level hospital care provided in patients’ homes. The proposed legislation, called the Preserving Telehealth, Hospital and Ambulance Access Act,... Read More

    FemTech Innovations: Prioritizing Apps for Women’s Health 

    Make no mistake, women’s health has been left behind in the United States. The U.S. leads developed nations in maternal morbidity,... Read More

    Make no mistake, women’s health has been left behind in the United States. The U.S. leads developed nations in maternal morbidity, and this medical crisis has trickled into every facet of women’s health. One of the driving forces behind this current state is a limited understanding of... Read More

    Dogs Entering US Must Be Six Months Old and Microchipped to Prevent Spread of Rabies

    NEW YORK (AP) — All dogs coming into the U.S. from other countries must be at least 6 months old... Read More

    NEW YORK (AP) — All dogs coming into the U.S. from other countries must be at least 6 months old and microchipped to help prevent the spread of rabies, according to new government rules published Wednesday. The new rules require vaccination for dogs that have been in countries... Read More

    May 8, 2024
    by Beth McCue
    Low Oxygen During Sleep and Sleep Apnea Could Be Linked to Late Onset Epilepsy

    WASHINGTON — The National Institutes of Health released the results of a new study on the link between low oxygen... Read More

    WASHINGTON — The National Institutes of Health released the results of a new study on the link between low oxygen levels while sleeping and epilepsy that first occurs after 60 years of age. The results of the study have been published in Sleep. “There’s increasing evidence... Read More

    European Medicines Agency Pulls Authorization for AstraZeneca's COVID Shot, at Company's Request

    LONDON (AP) — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according... Read More

    LONDON (AP) — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator. In an update on the European Medicines Agency's website Wednesday, the regulator said that the approval for AstraZeneca's Vaxzevria had been withdrawn “at... Read More

    Can Yogurt Reduce the Risk of Type 2 Diabetes?

    Sharp-eyed grocery shoppers may notice new labels in the dairy aisle touting yogurt as way to reduce the risk of... Read More

    Sharp-eyed grocery shoppers may notice new labels in the dairy aisle touting yogurt as way to reduce the risk of Type 2 diabetes. That’s because the U.S. Food and Drug Administration recently said it’s OK for producers of yogurt to make that claim — even though... Read More

    News From The Well
    scroll top